BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31802639)

  • 21. Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients.
    Tekeoglu S; Temiz Karadag D; Ozdemir Isik O; Yazici A; Cefle A
    Lupus; 2024 Mar; 33(3):298-311. PubMed ID: 38258530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay.
    Aldarmaki R; Al Khogali HI; Al Dhanhani AM
    Lupus; 2021 Apr; 30(5):845-851. PubMed ID: 33497303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood-Onset Systemic Lupus Erythematosus: A Cohort Study.
    Shakeel S; Ali SR; Karim F; Ishaq S; Qaiser I; Nayani K; Ahmed A
    J Coll Physicians Surg Pak; 2018 May; 28(5):365-369. PubMed ID: 29690965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of 1555 childhood-onset lupus in three groups based on distinct time intervals to disease diagnosis: a Brazilian multicenter study.
    Novak GV; Molinari BC; Ferreira JC; Sakamoto AP; Terreri MT; Pereira RMR; Saad-Magalhães C; Aikawa NE; Campos LM; Len CA; Appenzeller S; Ferriani VP; Silva MF; Oliveira SK; Islabão AG; Sztajnbok FR; Paim LB; Barbosa CM; Santos MC; Bica BE; Sena EG; Moraes AJ; Rolim AM; Spelling PF; Scheibel IM; Cavalcanti AS; Matos EN; Robazzi TC; Guimarães LJ; Santos FP; Silva CT; Bonfá E; Silva CA;
    Lupus; 2018 Sep; 27(10):1712-1717. PubMed ID: 30020023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.
    Vilá LM; Molina MJ; Mayor AM; Peredo RA; Santaella ML; Vilá S
    Lupus; 2006; 15(12):892-8. PubMed ID: 17211998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
    Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
    Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB; Bae SC
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Features and Disease Damage Risk Factors in an Egyptian SLE Cohort: A Multicenter Study.
    Afifi N; El Bakry SA; Mohannad N; Bassyouni IH; Elezz NFA; El-Shazly R; Hussein SA
    Curr Rheumatol Rev; 2021; 17(2):222-231. PubMed ID: 33243127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study.
    Alonso MD; Llorca J; Martinez-Vazquez F; Miranda-Filloy JA; Diaz de Teran T; Dierssen T; Vazquez-Rodriguez TR; Gomez-Acebo I; Blanco R; Gonzalez-Gay MA
    Medicine (Baltimore); 2011 Sep; 90(5):350-358. PubMed ID: 21857367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
    Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
    J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.
    Jallouli M; Frigui M; Hmida MB; Marzouk S; Kaddour N; Bahloul Z
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and clinical significance of lymphadenopathy and its histological subtypes in patients with systemic lupus erythematosus: a retrospective cohort study.
    Papachristodoulou E; Graef E; Magliulo D; Kyttaris V
    Rheumatol Int; 2023 Jul; 43(7):1277-1286. PubMed ID: 37097329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter longitudinal study of the prevalence and mortality rate of systemic lupus erythematosus patients in Oman: Oman Lupus Study.
    Al-Adhoubi NK; Al-Balushi F; Al Salmi I; Ali M; Al Lawati T; Al Lawati BSH; Abdwani R; Al Shamsi A; Al Kaabi J; Al Mashaani M; Krishna Jha D; Sayed S; Al-Araimi T; Liyanage P; Al Shirawi A; Al Wahshi HA
    Int J Rheum Dis; 2021 Jun; 24(6):847-854. PubMed ID: 34058079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
    Silva MF; Ferriani MP; Terreri MT; Pereira RM; Magalhães CS; Bonfá E; Campos LM; Okuda EM; Appenzeller S; Ferriani VP; Barbosa CM; Ramos VC; Lotufo S; Silva CA
    J Rheumatol; 2015 Dec; 42(12):2296-303. PubMed ID: 26568586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.
    Pamuk ON; Balci MA; Donmez S; Tsokos GC
    Lupus; 2016 Jan; 25(1):102-9. PubMed ID: 26345673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
    Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K
    Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
    J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.